Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

AMGN

Amgen (AMGN)

Amgen Inc
De:
Trier par:
 Showing the most relevant articles for your search:BIT:AMGN
DateHeureSourceTitreSymboleSociété
19/10/200920h57Dow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugNASDAQ:AMGNAmgen Inc.
19/10/200917h17Dow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoNASDAQ:AMGNAmgen Inc.
19/10/200915h55Dow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionNASDAQ:AMGNAmgen Inc.
16/10/200920h55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesNASDAQ:AMGNAmgen Inc.
14/10/200920h44Dow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionNASDAQ:AMGNAmgen Inc.
12/10/200916h57Dow Jones NewsDrug Stocks Edge Higher; DepoMed SinksNASDAQ:AMGNAmgen Inc.
01/10/200919h22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketNASDAQ:AMGNAmgen Inc.
23/09/200916h22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNASDAQ:AMGNAmgen Inc.
23/09/200911h59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNASDAQ:AMGNAmgen Inc.
22/09/200913h28Dow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsNASDAQ:AMGNAmgen Inc.
17/09/200922h04Dow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceNASDAQ:AMGNAmgen Inc.
17/09/200915h31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNASDAQ:AMGNAmgen Inc.
15/09/200923h52Dow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200923h39Dow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200918h22Dow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
25/08/200923h46Dow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyNASDAQ:AMGNAmgen Inc.
17/08/200915h40Dow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatNASDAQ:AMGNAmgen Inc.
14/08/200917h29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNASDAQ:AMGNAmgen Inc.
14/08/200901h34Dow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200900h51Dow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200900h03Dow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200923h13Dow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200922h10Dow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200921h38Dow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
11/08/200918h56Dow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemNASDAQ:AMGNAmgen Inc.
07/08/200919h01Dow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusNASDAQ:AMGNAmgen Inc.
04/08/200921h43Dow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200920h05Dow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200918h13Dow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsNASDAQ:AMGNAmgen Inc.
04/08/200900h01Dow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialNASDAQ:AMGNAmgen Inc.
 Showing the most relevant articles for your search:BIT:AMGN